The Latest Cardiac and Vascular News
DENVER–(BUSINESS WIRE)–Cleerly, a leader in AI-based cardiovascular imaging, will showcase new product updates at RSNA 2025, November 30 – December 4, 2025, at McCormick Place in Chicago, IL. At Booth #8039, Cleerly will demonstrate PowerScribe integration and newly added lesion-level reporting, discuss new clinical research findings, and provide guidance on the […]
SAN ANTONIO, Nov. 26, 2025 /PRNewswire/ — Vascular Perfusion Solutions, Inc. (VPS) announced a collaboration with the Wyss Institute at Harvard University, the University of Colorado, and the University of Wyoming under the Advanced Research Projects Agency for Health (ARPA-H) Tissue…
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
Cleary joins Restore as the company accelerates its clinical pathway toward advanced US studies OR YEHUDA, Israel, Nov. 26, 2025 /PRNewswire/ — Restore Medical Ltd., a privately held medical device company developing a novel transcatheter therapy for heart failure, today announced the…
New clearances expand the Rapid Enterprise Platform, advancing radiology precision, and elevating neurology and vascular care through deep clinical AI SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced the U.S. Food and Drug Administration (FDA) clearance of five new imaging […]
FORT MILL, S.C., Nov. 25, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced that the recent addition of key ablation procedures to ambulatory surgery centers (ASC) by Centers for Medicare and Medicaid services (CMS) provides a unique and new opportunity to expand the commercialization of LockeT.
New OPPS and PFS reimbursement rates give hospitals, imaging centers and physicians a unified path to use AI plaque analysis starting 2026 STAMFORD, Conn., Nov. 25, 2025 /PRNewswire/ — Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease,…
Late-Breaking Data Presented at Society of Vascular and Interventional Neurology Annual Meeting Demonstrated Excellent Reperfusion and Rapid Procedure Times with the Zoom Stroke System Using Large-Bore Intracranial Access, Asymmetric Aspiration, and Continuous Dual Aspiration CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced the presentation of late-breaking, real-world data from a multi-center review […]
SYDNEY, Nov. 24, 2025 (GLOBE NEWSWIRE) — AI and Medical Technology Company Echo IQ Limited (ASX: EIQ) (“Echo IQ” or “the Company”) is pleased to advise that it has completed its clinical validation for its heart failure clinical decision support software (“EchoSolv HF”) in collaboration with the Mayo Clinic Platform (“MCP”), a division of the Mayo Clinic, a top ranked US hospital. The MCP Validate program is a unique in-market AI evaluation program which generates an independent and objective report on accuracy, efficacy and susceptibility to bias for AI-based decision software (refer ASX Announcement 1 July 2025).
IRVINE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced results from an expanded cohort of 700 patients from the ALIGN-AR pivotal trial for the Trilogy THV System in high-risk patients with symptomatic, severe aortic regurgitation (AR). These results were published in The Lancet and simultaneously presented as part of the Late-Breaking Clinical Trial sessions at PCR London Valves.
